Nicotin Fruitmint Beta (Nicotine Resinate)

Nicotine resinate binds to nicotinic acetylcholine receptors in the brain, providing a controlled level of stimulation that mimics the effect of tobacco‑derived nicotine. This partial activation reduces the severity of withdrawal, making it easier for the user to taper off nicotine while maintaining some receptor activity.

The appropriate dose is determined by the prescribing healthcare professional based on the individual’s smoking history, level of dependence, and overall health. Dosage may be adjusted during the cessation program, and patients should follow the prescriber’s instructions without deviation.

Safety data for nicotine resinate during pregnancy and lactation are limited, and the pregnancy category is listed as unknown. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and the necessary import documentation.

Compared with nicotine patches or gum, nicotine resinate offers an oral formulation that can be taken in precise doses and may provide faster onset of action. Unlike nicotine replacement therapies that deliver nicotine via the skin or oral mucosa, nicotine resinate is absorbed systemically, which some users find more effective for managing cravings, though individual response varies.

Store the product at ambient temperature, preferably below 25 °C, in its original container. Protect it from moisture, direct sunlight, and extreme heat. Keep out of reach of children and do not use after the expiry date printed on the packaging.

Nicotin Fruitmint Beta is taken orally, usually with a glass of water. The exact timing (e.g., with meals or on an empty stomach) should follow the prescriber’s guidance. Swallow the tablet or capsule whole; do not crush or chew unless specifically instructed.

The most serious risks include severe allergic reactions such as anaphylaxis, cardiovascular events like hypertension or arrhythmias, seizures, and significant hypotension. Patients experiencing any of these symptoms should discontinue the product immediately and seek emergency medical care.

Individuals with uncontrolled hypertension, recent myocardial infarction, severe cardiovascular disease, known hypersensitivity to nicotine resinate, or children and adolescents should avoid using this product. It is also contraindicated in patients for whom nicotine replacement therapy is medically inappropriate, as determined by a healthcare professional.